HighLight Capital is a growth equity and venture capital firm primarily focused on healthcare, biotech, and consumer-related companies. Their strategy emphasizes long-term value creation through technology-driven innovation, leveraging expertise in chemical, biological, and materials science to improve manufacturing efficiency and human wellness, with an increasing focus on overseas investments.
50% of their portfolio is in Healthcare. They made 3 investments in the last 12 months. Average disclosed round size is $61.5M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
$3.8B
Top Stage
Series B
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 T-CURX | Series A | $17.7M | Dec 2025 |
 Allegria Therapeutics | Seed | $5.1M | Dec 2025 |
 Arthrosi Therapeutics | Series E | $153M | Oct 2025 |
| MMediLink Therapeutics | Series B | $70M | Mar 2022 |
Top Co-Investors
LYFE Capital1 shared
Legend Capital1 shared
Loyal Valley Capital1 shared
HLM Venture Partners1 shared
Bayern Kapital1 shared
Last updated: 28 April 2026